Tool for Selection of Digital Measurement Solutions in Clinical Trials

HealthXL community members and industry leaders from pharma, digital health companies and decentralized trials providers have come together to create this new open-access tool.

The tool helps sponsors select the best digital measurement technologies for clinical trial use in each particular trial. It also offers vendors a way to prepare a documentation package to support the sponsor evaluation process. 

This initiative continues to build upon the earlier work of the DiME V3 framework, the CTTI checklist and the HealthXL Vendor Assessment Guide. 

In combination with the 2021 HealthXL Vendor Assessment, this new tool can help you get a broad and deep evaluation of technology and vendor readiness for clinical trial use. 

Thank you to all our contributors:

  • Erwin De beuckelaer, Director Innovative Capabilities, Johnson
    & Johnson
  • Richie Bavasso, CEO/Co-Founder, nQ Medical 
  • Jim Howard, CEO, Readout Health
  • Peter Small, CMO, Hyfe
  • Daniela Deflorio, Company Director, DADAL Consulting Ltd 
  • Larry Liu, Sr. Director Digital Endpoints, Medable 
  • John Bunch, Global Business Capability Lead mHealth, Bristol Myers Squibb 
  • Jacek Lukawy, Innovation Program Director, Novartis 
  • Judit Faus i Garriga, Community Manager, HealthXL 

Get your free Tool today

Get your free report today

Thank you, download the report via the button below
Download now
Oops! Something went wrong while submitting the form.